ORCL
67
2
USB
61
11
NWL
50
6
STI
31
-16
ADI
47
2
VNO
50
-9
CNP
63
3
EQR
59
5
EXPE
91
3
CB
51
3
AXP
69
3
MTB
65
2
F
47
4
FLS
75
2
EFX
36
4
CI
52
7
RIG
58
4
SLG
66
2
PVH
57
5
FOXA
59
4
ORCL
67
2
USB
61
11
NWL
50
6
STI
31
-16
ADI
47
2
VNO
50
-9
CNP
63
3
EQR
59
5
EXPE
91
3
CB
51
3
AXP
69
3
MTB
65
2
F
47
4
FLS
75
2
EFX
36
4
CI
52
7
RIG
58
4
SLG
66
2
PVH
57
5
FOXA
59
4
Financhill
Back

GlycoMimetics Vs. Arbutus Biopharma Industry Stock Comparison

Sell
47

GLYC
GlycoMimetics

Last Price:
0.32
Seasonality Move:
31.73%
Sell
36

ABUS
Arbutus Biopharma

Last Price:
3.51
Seasonality Move:
15.21%
Sell
47
GlycoMimetics (GLYC) is a Sell

Is GlycoMimetics a Buy, Sell or Hold?

  • The current GlycoMimetics [GLYC] share price is $0.32. The Score for GLYC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • GLYC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.46. The Score for ABUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GLYC Stock Price Chart

What is GlycoMimetics's stock price today?

  • The GlycoMimetics share price today is $0.32
    The current trend is moderately bearish and GLYC is experiencing slight buying pressure.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.

GLYC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 47.99 Sell
Chaikin Money Flow: 366577 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.23 - 0.45) Sell
Bollinger Bands (100): (0.14 - 0.32) Buy

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 30.71 Sell
Chaikin Money Flow: -475329 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.61 - 4.03) Sell
Bollinger Bands (100): (3.57 - 4.13) Sell

GLYC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.38 Sell
20-day SMA: 0.38 Sell
50-day SMA: 0.25 Buy
200-day SMA: 0.98 Sell
8-day EMA: 0.37 Sell
20-day EMA: 0.35 Sell
50-day EMA: 0.3 Buy
200-day EMA: 0.74 Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.56 Sell
20-day SMA: 3.76 Sell
50-day SMA: 3.9 Sell
200-day SMA: 3.37 Buy
8-day EMA: 3.56 Sell
20-day EMA: 3.71 Sell
50-day EMA: 3.82 Sell
200-day EMA: 3.43 Buy

GlycoMimetics Earnings Growth & GLYC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

GlycoMimetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):